10.47USD+7.11%Mkt Cap: 61.01M USDP/E: 6.38Last update: 2026-06-01
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use …
Industry Peers
Medical Instruments & Supplies146.01BUSDP/E 50.0
86.09BDKKP/E 40.9
79.36BEURP/E 34.8
40.39BUSDP/E 25.6
30.12BUSDP/E 31.2
27.29BUSDP/E 18.1
25.22BCHFP/E 39.2
22.10BUSDP/E 41.8
Indicators:|
Key Statistics
Company
Market Cap61.01M USD
Enterprise Value—
Revenue (TTM)26.69K USD
Gross Profit26.69K USD
Net Income (TTM)9.17M USD
Revenue/Share0.0050 USD
Last Price10.47 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)6.38
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S2244.60
P/B1.13
EPS (TTM)1.64
EPS (Forward)—
52W Range
8.08036% of range14.76
52W High14.76 USD
52W Low8.080 USD
Profitability
Gross Margin100.00%
Oper. Margin-9660.55%
EBITDA Margin0.00%
Profit Margin89.00%
ROE19.98%
ROA19.93%
Growth
Revenue Growth-82.60%
Earnings Growth329.30%
Cash Flow & Leverage
Operating CF570.94K USD
CapEx (TTM)—
FCF Margin375.63%
FCF Yield0.16%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.08
Quick Ratio—
Book Value/Sh9.069 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJan 5, 2018
Pay DateJan 12, 2018
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)22.50 USD
Target Range22.00 USD – 23.00 USD
# Analysts2
Ownership
Shares Out.5.83M
Float2.57M
Insiders49.02%
Institutions7.00%
Short Interest
Short Ratio1.0d
Short % Float0.31%
Short % Out.0.16%
Shares Short9.07K
Short (prev mo.)3.23K
Technical
SMA 5010.21 (+2.6%)
SMA 20011.93 (-12.2%)
Beta0.29
S&P 52W Chg27.94%
Avg Vol (30d)7.14K
Avg Vol (10d)2.23K
Technical Indicators
RSI (14)41.0
MACD-0.0315
MACD Signal0.0771
MACD Hist.-0.1086
BB Upper11.42 USD
BB Middle10.44 USD
BB Lower9.461 USD
BB Width18.78%
ATR (14)0.6757 USD
Vol Ratio (20d)0.14x